{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-027781","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2026-06-08T21:53:19+00:00","discovered_at":"2026-06-09T10:05:00.301680+00:00","generated_at":"2026-06-09T10:08:33.237102+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Enveric Biosciences releases Q2 2026 investor presentation; no specific updates","bullets":["Investor presentation made available on June 8, 2026 via company website.","Materials intended for use in discussions with investors, analysts, and partners.","No financial results, guidance, or operational milestones disclosed in filing.","Presentation may be modified and reused in future stakeholder meetings."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-027781","json":"https://secwatch.observer/filing/0001493152-26-027781.json","markdown":"https://secwatch.observer/filing/0001493152-26-027781.md","text":"https://secwatch.observer/filing/0001493152-26-027781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315226027781/0001493152-26-027781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315226027781/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T10:08:33.237102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}